Showing results (231-240 of 351) with videos related to

Sort By:
Pageof 36
European Journal of Haematology|August 6, 2019
Reactivation and dynamics of cytomegalovirus and Epstein-Barr virus after rabbit antithymocyte globulin and cyclosporine for aplastic anemiaSung-Soo Park, Sung-Yeon Cho, Eunhee Han, et al.
Clinical Lymphoma, Myeloma & Leukemia|April 25, 2019
Clinical Outcomes of Fludarabine and Melphalan With an 800 cGy Total Body Irradiation Conditioning Regimen in Patients With Refractory or Relapsed Aggressive Non-Hodgkin Lymphoma Undergoing Allogeneic Hematopoietic Stem Cell TransplantationYoung-Woo Jeon, Seugyun Yoon, Gi June Min, et al.
Therapeutic Advances in Hematology|March 10, 2023
Superior survival outcome of blinatumomab compared with conventional chemotherapy for adult patients with relapsed or refractory B-cell precursor acute lymphoblastic leukemia: a propensity score-matched cohort analysisJae-Ho Yoon, Daehun Kwag, Jong-Hyuk Lee, et al.
Cytotherapy|August 5, 2023
Efficacy of ex vivo purging with CD34+ selection to maximize the effects of autologous stem cell transplantation in peripheral T-cell lymphoma patientsYoungwoo Jeon, Tong-Yoon Kim, Gi June Min, et al.
European Journal of Haematology|January 21, 2020
Role of pretransplant anti-thymocyte globulin in matched sibling donor stem cell transplantation after reduced intensity conditioning for myelodysplastic syndromeSeung-Ah Yahng, Gi-June Min, Sung-Soo Park, et al.
Cancers|January 21, 2023
Haploidentical versus Double-Cord Blood Stem Cells as a Second Transplantation for Relapsed Acute Myeloid LeukemiaJong-Hyuk Lee, Byung-Sik Cho, Daehun Kwag, et al.
Cancer Medicine|September 28, 2019
Clinical outcomes for ibrutinib in relapsed or refractory mantle cell lymphoma in real-world experienceYoung-Woo Jeon, Seugyun Yoon, Gi June Min, et al.
Acta Haematologica|March 18, 2011
Reduced-intensity conditioning regimen combined with low-dose total body irradiation in the treatment of myelodysplastic syndromeSung-Eun Lee, Jihyang Lim, Seung-Ah Yahng, et al.
Clinical Therapeutics|July 20, 2015
Cost-benefit Analysis of Posaconazole Versus Fluconazole or Itraconazole as a Primary Antifungal Prophylaxis in High-risk Hematologic Patients: A Propensity Score-matched AnalysisSung-Yeon Cho, Dong-Gun Lee, Jae-Ki Choi, et al.
European Journal of Haematology|May 30, 2020
Non-myeloablative matched sibling stem cell transplantation with the optional reinforced stem cell infusion for patients with hemoglobinopathiesSeung-Hwan Shin, Sung-Soo Park, Silvia Park, et al.
Pageof 36